Separation of Antiretrovirals

HPLC, UHPLC

Separation of Antiretrovirals

22 Jun, 2021

Published over 5 years ago. See the latest and most current information on HPLC, UHPLC.

Antiretrovirals have come back to the forefront of separations science at this moment in time, as they have found use in the fight against SARS-CoV-2.  Traditionally used for the treatment of HIVS/AIDS we have provided two application notes for the separation of Ritonavir and Lopinavir and also for the corticosteroid Dexamethasone which has also shown to be effective in lowering the risk of mortality.

Both of these application notes highlight how the use of simple mobile phase conditions can be utilised with a SpeedCore core-shell particle LC column in order to separate quickly and efficiently the mentioned compounds. 

Fast efficient LC separations are critical to ensure purity of drugs to market. Especially in the case of the drugs on the World Health Organisations (WHO) list of essential medicines which need to be abundantly available at highly cost-effective prices to assure supply is readily available to all nations.

To receive a copy of these application notes or for any other application or HPLC column related questions, please send an email to our tech support.

Latest News

Explore Our Other Sites

Labmate Online
Smart temperature control. Designed for the future.
Explore more Arrow
Envirotech Online
Vehicle-based methane detection system passes German suitability test
Explore more Arrow
Pollution Solutions Online
Large-scale liquefied biogas bunkering to become possible in the Port of Gothenburg in 2027
Explore more Arrow
Petro Online
PFAS reference standard combines ten analytes to support trace-level calibration
Explore more Arrow